Expression patterns of cardiac myofilament proteins

Circulation: Heart Failure

Volumn 2, Issue 4, 2009, Pages 325-333

  Theis, Jeanne L ^a   Bos, J Martijn ^a   Theis, Jason D ^a   Miller, Dylan V ^a   Dearani, Joseph A ^a   Schaff, Hartzell V ^a   Gersh, Bernard J ^a   Ommen, Steve R ^a   Moss, Richard L ^a   Ackerman, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiomyopathy; Genetics; Hypertrophy; Protein; Tissue

Indexed keywords

PROTEIN HYDROLYSATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GENOMICS; GENOTYPE; HEART LEFT VENTRICLE; HUMAN; HUMAN TISSUE; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; MALE; MISSENSE MUTATION; MUSCLE RESECTION; MYOFILAMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; CARDIAC MYOSINS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICROFILAMENTS; MIDDLE AGED; MUTATION; MYOSIN HEAVY CHAINS;

EID: 76449099538     PISSN: 19413289     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.108.789735     Document Type: Article

References (44)

1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAAMA. 2002;287:1308-1320.
2. Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Car-diovascMed. 2008;5:158-168.
3. Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, McGarry K, Seidman JG, Seidman CE. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest. 2002;109:357-362.
4. Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005;352:362-372.
5. Geier C, Perrot A, Ozcelik C, Binner P, Counsell D, Hoffmann K, Pilz B, Martiniak Y, Gehmlich K, van der Ven PF, Fürst DO, Vornwald A, von Hodenberg E, Nürnberg P, Scheffold T, Dietz R, Osterziel KJ. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation. 2003;107:1390-1395.
6. Hayashi T, Arimura T, Itoh-Satoh M, Ueda K, Hohda S, Inagaki N, Takahashi M, Hori H, Yasunami M, Nishi H, Koga Y, Nakamura H, Matsuzaki M, Choi BY, Bae SW, You CW, Han KH, Park JE, Knoll R, Hoshijima M, Chien KR, Kimura A. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol. 2004; 44:2192-2201.
7. Vasile VC, Ommen SR, Edwards WD, Ackerman MJ. A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 2006;345:998-1003.
8. Theis JL, Bos JM, Bartleson VB, Will ML, Binder J, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 2006;351:896-902.
9. Landstrom AP, Weisleder N, Batalden KB, Martijn Bos J, Tester DJ, Ommen SR, Wehrens XHT, Claycomb WC, Ko JK, Hwang M, Pan Z, Ma J, Ackerman MJ. Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J Mol Cell Cardiol. 2007;42:1026-1035.
10. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sar- comeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc. 2005;80:463-469.
11. Flashman E, Redwood C, Moolman-Smook J, Watkins H. Cardiac myosin-binding protein C: its role in physiology and disease. Circ Res. 2004;94:1279-1289.
12. Kunst G, Kress KR, Gruen M, Uttenweiler D, Gautel M, Fink RH. Myosin-binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2. Circ Res. 2000;86:51-58.
13. Weisberg A, Winegrad S. Alteration of myosin cross bridges by phos- phorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci USA. 1996;93:8999-9003.
14. Sebillon P, Bonne G, Flavigny J, Venin S, Rouche A, Fiszman M, Vikstrom K, Leinwand L, Carrier L, Schwartz K. COOH-terminal truncated human cardiac MyBP-C alters myosin filament organization. C R Acad Sci III. 2001;324:251-260.
15. Flavigny J, Souchet M, Sebillon P, Berrebi-Bertrand I, Hainque B, Mallet A, Bril A, Schwartz K, Carrier L. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J Mol Biol. 1999;294:443-456.
16. Van Driest SL, Vasile VC, Ommen SR, Will ML, Gersh BJ, Nishimura RA, Tajik AJ, Ackerman MJ. Myosin-binding protein C mutations and compound herterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44:1903-1910.
17. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy [see comment]. N Engl J Med. 1998;338:1248-1257.
18. Erdmann J, Raible J, Maki-Abadi J, Hummel M, Hammann J, Wollnik B, Frantz E, Fleck E, Hetzer R, Regitz-Zagrosek V. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2001;38:322-330.
19. Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, Greaser ML, Powers PA, Moss RL. Hypertrophic cardiomyopathy in cardiac myosin-binding protein-C knockout mice. Circ Res. 2002;90:594-601.
20. Binder J, Ommen SR, Gersh BJ, Van Driest SL, Tajik AJ, Nishimura RA, Ackerman MJ. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc. 2006;81:459-467.
21. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. A mouse model of myosin-binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest. 1998;102:1292-1300.
22. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. In vivo modeling of myosin-binding protein C familial hypertrophic cardiomy- opathy: a mouse model of myosin-binding protein C human familial hypertrophic cardiomyopathy. Circ Res. 1999;85:841-847.
23. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science. 1996;272:731-734.
24. Marian AJ, Wu Y, Lim DS, McCluggage M, Youker K, Yu QT, Brugada R, DeMayo F, Quinones M, Roberts R. A transgenic rabbit model for human hypertrophic cardiomyopathy. J Clin Invest. 1999;104: 1683-1692.
25. Flavigny J, Robert P, Camelin JC, Schwartz K, Carrier L, Berrebi- Bertrand I. Biomolecular interactions between human recombinant /3-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomy- opathy. Cardiovasc Res. 2003;60:388-396.
26. Fatkin D, Christe ME, Aristizabal O, McConnell BK, Srinivasan S, Schoen FJ, Seidman CE, Turnbull DH, Seidman JG. Neonatal cardiomy-opathy in mice homozygous for the Arg403Gln mutation in the a cardiac myosin heavy chain gene. J Clin Invest. 1999;103:147-153.
27. Gruen M, Gautel M. Mutations in /3-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. J Mol Biol. 1999;286: 933-949.
28. Carrier L, Knoll R, Vignier N, Keller DI, Bausero P, Prudhon B, Isnard R, Ambroisine ML, Fiszman M, Ross J Jr, Schwartz K, Chien KR. Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc Res. 2004;63:293-304.
29. McConnell BK, Fatkin D, Semsarian C, Jones KA, Georgakopoulos D, Maguire CT, Healey MJ, Mudd JO, Moskowitz IP, Conner DA, Giewat M, Wakimoto H, Berul CI, Schoen FJ, Kass DA, Seidman CE, Seidman JG. Comparison of two murine models of familial hypertrophic cardio- myopathy. Circ Res. 2001;88:383-389.
30. McConnell BK, Jones KA, Fatkin D, Arroyo LH, Lee RT, Aristizabal O, Turnbull DH, Georgakopoulos D, Kass D, Bond M, Niimura H, Schoen FJ, Conner D, Fischman DA, Seidman CE, Seidman JG. Dilated cardio-myopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest. 1999;104:1235-1244.
31. Moolman-Smook J, Flashman E, de Lange W, Li Z, Corfield V, Redwood C, Watkins H. Identification of novel interactions between domains of myosin-binding protein-C that are modulated by hypertrophic cardiomy-opathy missense mutations. Circ Res. 2002;91:704-711.
32. Oakley CE, Chamoun J, Brown LJ, Hambly BD. Myosin-binding pro-tein-C: enigmatic regulator of cardiac contraction. Int J Biochem Cell Biol. 2007;39:2161-2166.
33. Lekanne Deprez RH, Muurling-Vlietman JJ, Hruda J, Baars MJ, Wijnaendts LC, Stolte-Dijkstra I, Alders M, van Hagen JM. Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound het- erozygous mutations in the MYBPC3 gene. J Med Genet. 2006;43: 829-832.
34. Xin B, Puffenberger E, Tumbush J, Bockoven JR, Wang H. Homozy- gosity for a novel splice site mutation in the cardiac myosin-binding protein C gene causes severe neonatal hypertrophic cardiomyopathy. Am J Med Genet A. 2007;143:2662-2667.
35. Moolman JA, Reith S, Uhl K, Bailey S, Gautel M, Jeschke B, Fischer C, Ochs J, McKenna WJ, Klues H, Vosberg HP. A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease pen- etrance. Circulation. 2000;101:1396-1402.
36. Rottbauer W, Gautel M, Zehelein J, Labeit S, Franz WM, Fischer C, Vollrath B, Mall G, Dietz R, Kubler W, Katus HA. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J Clin Invest. 1997;100:475-482.
37. Gilbert R, Kelly MG, Mikawa T, Fischman DA. The carboxyl terminus of myosin-binding protein C (MyBP-C, C-protein) specifies incorporation into the A-band of striated muscle. J Cell Sci. 1996;109(Part 1):101-111.
38. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol. 1996;58:447-481.
39. Sarikas A, Carrier L, Schenke C, Doll D, Flavigny J, Lindenberg KS, Eschenhagen T, Zolk O. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin-binding protein C mutants. Cardiovasc Res. 2005;66:33-44.
40. Stelzer JE, Dunning SB, Moss RL. Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium. Circ Res. 2006;98:1212-1218.
41. Stelzer JE, Fitzsimons DP, Moss RL. Ablation of myosin-binding protein-C accelerates force development in mouse myocardium. Biophys J. 2006;90:4119-4127.
42. Davis JS, Hassanzadeh S, Winitsky S, Lin H, Satorius C, Vemuri R, Aletras AH, Wen H, Epstein ND. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell. 2001;107:631-641.
43. Pringle JW. The Croonian Lecture, 1977. Stretch activation of muscle: function and mechanism. Proc R Soc Lond B Biol Sci. 1978;201: 107-130.
44. Palmer BM, Georgakopoulos D, Janssen PM, Wang Y, Alpert NR, Belardi DF, Harris SP, Moss RL, Burgon PG, Seidman CE, Seidman JG, Maughan DW, Kass DA. Role of cardiac myosin-binding protein C in sustaining left ventricular systolic stiffening. Circ Res. 2004;94:1249-1255.